Compared with the healthy controls, the level of sLOX-1 in stage I–II NSCLC group was significantly increased (p < 0.001), which means that the high expression of sLOX-1 has certain auxiliary value for the diagnosis of NSCLC. The gene discussed is OLR1; the disease is non-small cell lung carcinoma.